Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remco de Brouwer

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 6, 2025
Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohortFrederik E Deiman, Remco de Brouwer, Lukas Baumhove, et al.
Heart Rhythm|June 10, 2022
Value of genetic testing in the diagnosis and risk stratification of arrhythmogenic right ventricular cardiomyopathyRemco de Brouwer, Laurens P Bosman, Sophia Gripenstedt, et al.
Cardiovascular Research|April 25, 2026
Plasma proteomics stratification identifies phospholamban R14del carriers at risk for disease progressionFrederik E Deiman, Taner Arslan, Remco de Brouwer, et al.
Frontiers in Cardiovascular Medicine|January 31, 2022
Exploring the Correlation Between Fibrosis Biomarkers and Clinical Disease Severity in PLN p.Arg14del PatientsStephanie M van der Voorn, Mimount Bourfiss, Anneline S J M Te Riele, et al.
Journal of Cardiovascular Translational Research|January 9, 2023
Phenotypic and Genetic Factors Associated with Absence of Cardiomyopathy Symptoms in PLN:c.40_42delAGA CarriersEsteban A Lopera-Maya, Shuang Li, Remco de Brouwer, et al.
Heart Rhythm|November 12, 2021
Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiogramsRemco de Brouwer, Laura M G Meems, Tom E Verstraelen, et al.
The International Journal of Cardiovascular Imaging|August 11, 2023
Deep neural network-based clustering of deformation curves reveals novel disease features in PLN pathogenic variant carriersKarim Taha, Rutger R van de Leur, Melle Vessies, et al.
European Heart Journal. Cardiovascular Imaging|September 13, 2021
Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriersKarim Taha, Tom E Verstraelen, Remco de Brouwer, et al.
International Journal of Molecular Sciences|March 10, 2022
Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein AggregationTim R Eijgenraam, Nienke M Stege, Vivian Oliveira Nunes Teixeira, et al.
JACC. Heart Failure|August 11, 2023
Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort StudyMark Jansen, Remco de Brouwer, Fahima Hassanzada, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 6, 2025
Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohortFrederik E Deiman, Remco de Brouwer, Lukas Baumhove, et al.
Heart Rhythm|June 10, 2022
Value of genetic testing in the diagnosis and risk stratification of arrhythmogenic right ventricular cardiomyopathyRemco de Brouwer, Laurens P Bosman, Sophia Gripenstedt, et al.
Cardiovascular Research|April 25, 2026
Plasma proteomics stratification identifies phospholamban R14del carriers at risk for disease progressionFrederik E Deiman, Taner Arslan, Remco de Brouwer, et al.
Frontiers in Cardiovascular Medicine|January 31, 2022
Exploring the Correlation Between Fibrosis Biomarkers and Clinical Disease Severity in PLN p.Arg14del PatientsStephanie M van der Voorn, Mimount Bourfiss, Anneline S J M Te Riele, et al.
Journal of Cardiovascular Translational Research|January 9, 2023
Phenotypic and Genetic Factors Associated with Absence of Cardiomyopathy Symptoms in PLN:c.40_42delAGA CarriersEsteban A Lopera-Maya, Shuang Li, Remco de Brouwer, et al.
Heart Rhythm|November 12, 2021
Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiogramsRemco de Brouwer, Laura M G Meems, Tom E Verstraelen, et al.
The International Journal of Cardiovascular Imaging|August 11, 2023
Deep neural network-based clustering of deformation curves reveals novel disease features in PLN pathogenic variant carriersKarim Taha, Rutger R van de Leur, Melle Vessies, et al.
European Heart Journal. Cardiovascular Imaging|September 13, 2021
Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriersKarim Taha, Tom E Verstraelen, Remco de Brouwer, et al.
International Journal of Molecular Sciences|March 10, 2022
Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein AggregationTim R Eijgenraam, Nienke M Stege, Vivian Oliveira Nunes Teixeira, et al.
JACC. Heart Failure|August 11, 2023
Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort StudyMark Jansen, Remco de Brouwer, Fahima Hassanzada, et al.
Pageof 2